Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAlco, G.
dc.contributor.authorIgdem, S. I.
dc.contributor.authorErcan, T.
dc.contributor.authorDincer, M.
dc.contributor.authorSenturk, R.
dc.contributor.authorAtilla, S.
dc.contributor.authorOkkan, S.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T16:04:21Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T16:04:21Z
dc.date.issued2010
dc.identifier.issn0007-1285
dc.identifier.urihttps://dx.doi.org/10.1259/bjr/25788274
dc.identifier.urihttp://hdl.handle.net/11446/3285
dc.descriptionWOS: 000284357200015en_US
dc.descriptionPubMed ID: 21088091en_US
dc.description.abstractThe aim of this study is to evaluate the coverage of axillary nodal volumes with high tangent fields (HTF) in breast radiotherapy and to determine the utility of customised blocking. The treatment plans of 30 consecutive patients with early breast cancer were evaluated. The prescription dose was 50 Gy to the whole breast. Axillary level I-II lymph node volumes were delineated and the cranial border of the tangential fields was set just below the humeral head to create HTF. Dose-volume histograms (DVH) were used to calculate the doses received by axillary nodal volumes. In a second planning set, HTF were modified with multileaf collimators (MLC-HTF) to obtain an adequate dose coverage of axillary nodes. The mean doses of the axillary nodes, the ipsilateral lung and heart were compared between the two plans (HTF vs MLC-HTF) using a paired sample t-test. The doses received by 95% of the breast volumes were not significantly different for the two plans. The doses received by 95% of the level I and II axillary volumes were 16.79 Gy and 11.59 Gy, respectively, for HTF, increasing to 47.2 Gy and 45.03 Gy, respectively, for MLC-HTF. Mean lung doses and per cent volume of the ipsilateral lung receiving 20 Gy (V20) were also increased from 6.47 Gy and 10.47%, respectively, for HTF, to 9.56 Gy and 16.77%, respectively, for MLC-HTF. Our results suggest that HTF do not adequately cover the level I and II axillary lymph node regions. Modification of HTF with MLC is necessary to obtain an adequate coverage of axillary levels without compromising healthy tissue in the majority of the patients.en_US
dc.language.isoengen_US
dc.publisherBRITISH INST RADIOLOGYen_US
dc.identifier.doi10.1259/bjr/25788274en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleCoverage of axillary lymph nodes with high tangential fields in breast radiotherapyen_US
dc.typearticleen_US
dc.relation.journalBRITISH JOURNAL OF RADIOLOGYen_US
dc.departmentDBÜen_US
dc.identifier.issue996en_US
dc.identifier.volume83en_US
dc.identifier.startpage1072en_US
dc.identifier.endpage1076en_US
dc.contributor.authorID0000-0002-3592-9923en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Alco, G. -- Ercan, T. -- Dincer, M. -- Atilla, S. -- Zengin, F. Oral] Florence Nightingale Gayrettepe Hosp, Dept Radiat Oncol, TR-34340 Istanbul, Turkey -- [Igdem, S. I. -- Okkan, S.] Istanbul Bilim Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey -- [Senturk, R.] Florence Nightingale Gayrettepe Hosp, Dept Radiol, TR-34340 Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster